Pharmocann Global Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was ILS 8.037 million compared to ILS 4.571 million a year ago. Operating loss was ILS 5.988 million compared to ILS 2.424 million a year ago. Net loss was ILS 4.814 million compared to ILS 2.733 million a year ago. Basic loss per share from continuing operations was ILS 0.072 compared to ILS 0.041 a year ago.